ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Enzymatic Synthesis of NMN: Greener and More Efficient
February 19, 2021NMN, i.e., nicotinamide mononucleotide (Fig. 1), is a reaction product of nicotinamide phosphoribosyltransferase (NAMPT). -
Antengene announces China’s NMPA approval for IND application for ATG-019 clinical trial
April 06, 2021Antengene has announced that China’s National Medical Products Administration (NMPA) has given approval to investigational new drug (IND) application for Phase I clinical trials of ATG-019 (monotherapy or combined with niacin ER) in patients with ...
Pharma Sources Insight January 2025
